Pathophysiology of status epilepticus

被引:100
|
作者
Walker, Matthew C. [1 ]
机构
[1] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England
关键词
Status epilepticus; Drug resistance; Reactive oxygen species; Mitochondria; Excitotoxicity; TEMPORAL-LOBE EPILEPSY; REFRACTORY STATUS EPILEPTICUS; SUSTAINING STATUS EPILEPTICUS; GABA(A) RECEPTORS; NITRIC-OXIDE; KAINATE MODEL; NADPH OXIDASE; CELL-DEATH; RAT HIPPOCAMPUS; NEURONAL DEATH;
D O I
10.1016/j.neulet.2016.12.044
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Status epilepticus (SE) is the maximal expression of epilepsy with a high morbidity and mortality. It occurs due to the failure of mechanisms that terminate seizures. Both human and animal data indicate that the longer a seizure lasts, the less likely it is to stop. Recent evidence suggests that there is a critical transition from an ictal to a post-ictal state, associated with a transition from a spatio-temporally desynchronized state to a highly synchronized state, respectively. As SE continues, it becomes progressively resistant to drugs, in particular benzodiazepines due partly to NMDA receptor-dependent internalization of GABA(A) receptors. Moreover, excessive calcium entry into neurons through excessive NMDA receptor activation results in activation of nitric oxide synthase, cal pains, and NADPH oxidase. The latter enzyme plays a critical part in the generation of seizure-dependent reactive oxygen species. Calcium also accumulates in mitochondria resulting in mitochondrial failure (decreased ATP production), and opening of the mitochondria(permeability transition pore. Together these changes result in status epilepticus-dependent neuronal death via several pathways. Multiple downstream mechanisms including inflammation, break down of the blood-brain barrier, and changes in gene expression can contribute to later pathological processes including chronic epilepsy and cognitive decline. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 50 条
  • [21] Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment
    Niquet, Jerome
    Baldwin, Roger
    Suchomelova, Lucie
    Lumley, Lucille
    Naylor, David
    Eavey, Roland
    Wasterlain, Claude G.
    COUNTERMEASURES AGAINST CHEMICAL THREATS II, 2016, 1378 : 166 - 173
  • [22] Status epilepticus [Status epilepticus]
    Feddersen B.
    Trinka E.
    Der Nervenarzt, 2012, 83 (2) : 187 - 194
  • [23] Status Epilepticus and Refractory Status Epilepticus Management
    Abend, Nicholas S.
    Bearden, David
    Helbig, Ingo
    McGuire, Jennifer
    Narula, Sona
    Panzer, Jessica A.
    Topjian, Alexis
    Dlugos, Dennis J.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2014, 21 (04) : 263 - 274
  • [24] TONIC STATUS EPILEPTICUS PRESENTING AS ABSENCE STATUS EPILEPTICUS
    GOLDSTICK, L
    MORRIS, HH
    DINNER, DS
    LUDERS, H
    LESSER, RP
    WYLLIE, E
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1986, 63 (03): : P43 - P44
  • [25] STATUS EPILEPTICUS
    JOSEPHSON, DA
    AMERICAN FAMILY PHYSICIAN, 1974, 10 (04) : 168 - 173
  • [26] Status epilepticus
    Hemphill, J. C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 5 - 5
  • [27] STATUS EPILEPTICUS
    SHIELDS, WD
    PEDIATRIC CLINICS OF NORTH AMERICA, 1989, 36 (02) : 383 - 393
  • [28] Status epilepticus
    TelleriaDiaz, A
    GomezFernandez, L
    REVISTA DE NEUROLOGIA, 1997, 25 (144) : 1246 - 1256
  • [29] Status epilepticus
    Pellock, JM
    Leszczyszyn, DJ
    EPILEPSY AND DEVELOPMENTAL DISABILITIES, 2002, : 93 - 110
  • [30] Status epilepticus
    Adapa, Ram
    Absalom, Anthony R.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2009, 10 (03): : 137 - 140